CEO and co-founder of Inceptive
A co-author of the Transformer paper who left Google to co-found Inceptive, which uses deep learning to design RNA medicines.
Jakob Uszkoreit is the CEO and co-founder of Inceptive Nucleics, based in Palo Alto, California. He holds a master's degree in computer science and mathematics from Technische Universität Berlin. As a senior software engineer at Google he did deep learning research at Google Brain, built the language understanding team for Google Assistant, and worked on Google Translate in its early days.
He is one of the eight co-authors of the 2017 paper "Attention Is All You Need," which introduced the Transformer architecture. In 2021 he co-founded Inceptive with Stanford University's Rhiju Das to use Transformers to create "biological software": the company designs mRNA molecules with neural networks, tests them, and licenses them to pharmaceutical companies for clinical trials. Inceptive raised $100 million from investors including Nvidia and Andreessen Horowitz. Uszkoreit has described a "moral obligation" to use Transformers to develop new vaccines and drug treatments.
One of eight co-authors of "Attention Is All You Need" (2017), which introduced the Transformer architecture.
Co-founded Inceptive in 2021 with Stanford's Rhiju Das to design RNA molecules with deep learning; the company raised $100 million from investors including Nvidia and Andreessen Horowitz.
At Google, built the language understanding team for Google Assistant and worked on Google Translate in its early days.